Comments
Loading...
Athira Pharma (NASDAQ:ATHA) Stock Quotes, Forecast and News Summary
Athira Pharma Stock (NASDAQ: ATHA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Athira Pharma (ATHA) stock?
You can purchase shares of Athira Pharma (NASDAQ:ATHA) through any online brokerage.
Who are Athira Pharma (ATHA) competitors?
Other companies in Athira Pharma’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP) and Lipocine (NASDAQ:LPCN).
What is the forecast, or price target, for Athira Pharma (ATHA) stock?
Athira Pharma has a consensus price target of $13.25.
What is the current price for Athira Pharma (ATHA)?
The stock price for Athira Pharma (NASDAQ: ATHA) is $0.6435 last updated November 22, 2024 at 3:31 PM EST.
Does Athira Pharma (ATHA) pay a dividend?
There are no upcoming dividends for Athira Pharma.
When is Athira Pharma (NASDAQ:ATHA) reporting earnings?
Athira Pharma’s Q4 earnings are confirmed for Thursday, February 20, 2025.
Is Athira Pharma (ATHA) going to split?
There is no upcoming split for Athira Pharma.
What sector and industry does Athira Pharma (ATHA) operate in?
Athira Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.